Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the
severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem
cell transplantation.
PURPOSE: This randomized clinical trial is studying how well Traumeel® S works in preventing
or treating mucositis in young patients who are receiving chemotherapy with or without
total-body irradiation before undergoing stem cell transplantation.